Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Before borrowing money for credit card debt, consider the interest rates and repayment terms. Make informed decisions to avoid further financial strain.
23,246 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Investing in healthcare in 2026 means choosing between stability and potential high growth. This original guide weigh...
In a market facing higher-rate reality and volatile swings, retirees increasingly prefer steady cash flows from incom...
The hype around SpaceX often drowns out solid opportunities in AI-powered space companies. This guide shines a light ...
As the Iran conflict intensified in early 2026, gold failed to rally as expected. A hypothetical $10,000 in gold woul...
A retiree’s move to Vermont to be near grandkids uncovers a hidden state tax on Social Security. The change upends re...
Agentic AI changes how data centers think and act. This guide breaks down AMD, ARM, and Intel to identify the intel: ...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
I’m a fan of Costco as a retailer, but my investing stance is stubbornly conservative. Here’s the core reason haven't...
Lantheus is steering a strategic shift toward PET radiodiagnostics, aiming to unlock new growth. This article breaks ...
Bitcoin slides toward $60,000 raise fresh concerns for BLOK, the blockchain-focused ETF. This report explains potenti...
As Ituran gears up for its 2025 earnings, investors want clarity on growth, margins, and cash flow. This guide breaks...